UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058609
Receipt number R000066962
Scientific Title Evaluation of the usefulness of an intraoperative focus point automatic identification model using deep learning in laparoscopic cholecystectomy
Date of disclosure of the study information 2025/07/30
Last modified on 2025/07/27 09:48:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the usefulness of an intraoperative focus point automatic identification model using deep learning in laparoscopic cholecystectomy

Acronym

Evaluation of the usefulness of an intraoperative focus point automatic identification model using deep learning in laparoscopic cholecystectomy

Scientific Title

Evaluation of the usefulness of an intraoperative focus point automatic identification model using deep learning in laparoscopic cholecystectomy

Scientific Title:Acronym

Evaluation of the usefulness of an intraoperative focus point automatic identification model using deep learning in laparoscopic cholecystectomy

Region

Japan


Condition

Condition

Gallstone disease, Gallbladder polyps, Chronic cholecystitis

Classification by specialty

Surgery in general Hepato-biliary-pancreatic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In recent years, deep learning has attracted attention from researchers in engineering and medical fields, not only in the field of image recognition, due to its high performance and wide applicability compared to conventional algorithms.In our previous research, we developed a model that automatically predicts a surgeon's gaze point during surgery based on labeling data of anatomical structures and artificial objects in surgical videos. Specifically, in laparoscopic cholecystectomy, we noted that the tip of the right-hand forceps is often close to the surgeon's gaze point and devised an algorithm (new algorithm) that predicts the gaze point based on the historical position information of the right-hand forceps tip.Originally, one of the objectives of constructing a system to predict gaze points was to automate camera operations during laparoscopic surgery and reduce the human resources required by surgeons. To achieve this, we considered it useful to fix the laparoscopic camera externally and proceed with surgery while enlarging the gaze point. Furthermore, by combining this with technology that adjusts the enlarged field of view via voice input, we established a system that can be used in actual surgery.As we aim to introduce this system into clinical practice, the objective of this study is to evaluate the usefulness of the aforementioned new algorithm. While it is possible to perform surgery by simply tracking the tip of the right-hand forceps as the point of focus, the use of the new algorithm is expected to enable camera movements that more closely resemble those performed by surgeons during actual laparoscopic surgery.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We will compare the times deemed appropriate and inappropriate for surgical videos for each video and evaluate the usefulness of the new algorithm and select the most appropriate algorithm. We will also compare postoperative outcomes such as the length of hospital stay including patient information, the incidence of complications within 30 days, and the readmission rate within 90 days.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

New patient cohort: Patients who undergo laparoscopic cholecystectomy at the Department of Hepatobiliary and Pancreatic Surgery and Organ Transplantation, The University of Tokyo Hospital, between the approval date and November 30, 2026, and who have provided informed consent.Specifically, this study excludes cases with severe gallbladder inflammation, such as acute cholecystitis following PTGBD or cholangitis with yellow granuloma, and instead focuses on cases with mild gallbladder inflammation, such as gallbladder polyps, gallstone disease, or mild chronic cholecystitis.
Control group: Patients who underwent laparoscopic cholecystectomy at the Department of Hepatobiliary and Pancreatic Surgery, Tokyo University Hospital, between January 2008 and May 2025. The study focuses on cases with minimal gallbladder inflammation.

Key exclusion criteria

Patients aged 17 years or younger. Patients who are unable to give consent. Patients who have previously undergone laparoscopic cholecystectomy and have refused to participate.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kiyoshi
Middle name
Last name Hasegawa

Organization

The University of Tokyo Hospital

Division name

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery

Zip code

113-0033

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Email

kihase-tky@umin.ac.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Oikawa

Organization

The University of Tokyo Hospital

Division name

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery

Zip code

113-0033

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Homepage URL


Email

oikawar-sur@h.u-tokyo.ac.jp


Sponsor or person

Institute

The University of Tokyo hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Graduate School of Medicine, The University of Tokyo

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

Tel

03-5841-0818

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 07 Month 17 Day

Date of IRB

2025 Year 07 Month 17 Day

Anticipated trial start date

2025 Year 07 Month 17 Day

Last follow-up date

2026 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

1 This study includes patients who were determined to be eligible for laparoscopic cholecystectomy within the scope of routine clinical practice at the Department of Hepatobiliary and Pancreatic Surgery and Artificial Organ Transplantation, Tokyo University Hospital.
2 Prior to the procedure, patients undergoing the surgery will receive preoperative explanations about the procedure and obtain informed consent. Following this, they will be informed about the study and obtain informed consent for participation.
3 The surgery will be performed by the surgeon, assistant, and laparoscopic surgeon as usual. Two monitors will be used, with one displaying the standard camera view and the other showing real-time magnification of the right-hand forceps tip.
4 After port insertion and adhesion separation are completed, and the standard cholecystectomy technique is initiated, the surgeon will fix the scope using an external scope holder and proceed with the surgery while viewing the magnified image of the right-hand forceps tip or fixed images as needed, starting from approximately 5 minutes after the initiation of the cystic duct neck processing and approximately 5 minutes after the division of the cystic duct and cystic artery.During all other times, the scope operator operates the scope as usual to proceed with the surgery.
5 After surgery, the enlarged images from the right-hand forceps tip and the fixed images are recorded. By applying a new algorithm with multiple patterns to the fixed images, additional enlarged images are created.
6 While the surgeon reviews the surgical video, they are asked to continuously press a button at their fingertips during scenes deemed inappropriate as the surgical field and release it during appropriate scenes.
7 Compare the times deemed appropriate or inappropriate for each video to evaluate the usefulness of the new algorithm and select the most suitable algorithm.


Management information

Registered date

2025 Year 07 Month 27 Day

Last modified on

2025 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066962